Private company

Adamas Pharmaceuticals (United States)

Company in Emeryville, United States.1

Last updated Oct 18, 2026.

Overview

2002Founded1
  • IndustryPharmaceutical Preparations1
  • HeadquartersEmeryville1
  • Websitewww.adamaspharma.com
  • Incorporated inDE3
  • Business address1900 Powell St., Suite 1000, Emeryville, Ca 946083
  • Filer categoryNon-accelerated filer, Smaller reporting company3

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2020

-59.3%Operating margin4
-77.1%Net margin4
36.3%Revenue growth, 20204
-$50.7MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2020

  • Cost of revenue2¢$2.0M
  • Research and development7¢$9.7M
  • Selling, general and admin81¢$106.8M
  • Interest11¢$14.0M

Out of $74.5M in revenue.4 The company lost money this year.

Financial statements

Revenue56784$74.5M in 2020+33% since 2014
0$20.0M$40.0M$60.0M$80.0M2014: $55.8M$55.8M20142015: $1.9M$1.9M2015−97%2016: $572.0K$572.0K2016−70%2017: $571.0K$571.0K2017−0%2018: $34.0M$34.0M2018+5863%2019: $54.6M$54.6M2019+60%2020: $74.5M$74.5M2020+36%
Operating income56784-$44.2M in 2020
-$150.0M-$100.0M-$50.0M0$50.0M2014: $18.5M$18.5M20142015: -$57.4M-$57.4M20152016: -$61.0M-$61.0M2016+6%2017: -$87.9M-$87.9M2017+44%2018: -$115.0M-$115.0M2018+31%2019: -$92.2M-$92.2M2019−20%2020: -$44.2M-$44.2M2020−52%
Net income56784-$57.4M in 2020
-$150.0M-$100.0M-$50.0M0$50.0M2014: $10.2M$10.2M20142015: -$51.8M-$51.8M20152016: -$60.1M-$60.1M2016+16%2017: -$89.5M-$89.5M2017+49%2018: -$131.0M-$131.0M2018+46%2019: -$105.2M-$105.2M2019−20%2020: -$57.4M-$57.4M2020−45%
Fiscal year2014201520162017201820192020
Revenue$55.8M5$1.9M6$572.0K7$571.0K8$34.0M8$54.6M4$74.5M4
Cost of revenue$06$07$17.0K8$633.0K8$2.5M4$2.0M4
Research and development$21.9M5$35.9M6$31.2M7$27.2M8$39.3M8$30.0M4$9.7M4
Selling, general and admin$23.5M6$30.3M7$61.3M8$109.1M8$114.4M4$106.8M4
Operating income$18.5M5-$57.4M6-$61.0M7-$87.9M8-$115.0M8-$92.2M4-$44.2M4
Interest$06$07$4.6M8$19.1M8$15.0M4$14.0M4
Income tax$7.4M5-$5.3M6-$115.0K7-$1.7M8$08$04$04
Net income$10.2M5-$51.8M6-$60.1M7-$89.5M8-$131.0M8-$105.2M4-$57.4M4
Earnings per share$0.605-$2.865-$2.775
Earnings per share (diluted)$0.535-$2.865-$2.775

Compare Adamas Pharmaceuticals (United States) with another company

Former names

  • NeuroMolecular Pharmaceuticals IncMay 19, 2005 to Jul 17, 20063

Timeline

  1. 2002Founded Founded1

Recent filings

  1. Nov 24, 20218-K
  2. Nov 24, 20214
  3. Nov 24, 20214
  4. Nov 24, 20214
  5. Nov 24, 20214
  6. Nov 24, 20214
  7. Nov 24, 20214
  8. Nov 24, 20214
  9. Nov 24, 20214
  10. Nov 24, 20214
  11. Nov 24, 20214
  12. Nov 10, 202110-Q

Every filing from the last three years, summarized. The full record is on SEC EDGAR.2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9